Aphria Inc. (APHA)
Stock Price:
$4.30 USD
-0.06 (-1.38%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
1.15B |
| Revenue (ttm) |
176.95M |
| Net Income (ttm) |
-12.31M |
| Shares Out |
267.59M |
| EPS (ttm) |
0.30 |
| PE Ratio |
14.33 |
| Forward PE |
1,000.00 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 2, 2020 |
| Last Price |
$4.30 |
| Previous Close |
$4.36 |
| Change ($) |
-0.06 |
| Change (%) |
-1.38% |
| Day's Open |
4.42 |
| Day's Range |
4.30 - 4.42 |
| Day's Volume |
2,501,949 |
| 52-Week Range |
1.95 - 7.60 |
More Stats
| Market Cap |
1.15B |
| Enterprise Value |
1.05B |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
267.59M |
| Float |
267.05M |
| EPS (basic) |
n/a |
| EPS (diluted) |
0.30 |
| FCF / Share |
-0.80 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
6.98% |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
38.38M |
| Short Ratio |
4.51 |
| Short % of Float |
n/a |
| Beta |
2.08 |
| PE Ratio |
14.33 |
| Forward PE |
1,000.00 |
| P/FCF Ratio |
n/a |
| PS Ratio |
6.50 |
| PB Ratio |
0.88 |
| Revenue |
176.95M |
| Operating Income |
-108.32M |
| Net Income |
-12.31M |
| Free Cash Flow |
-195.16M |
| Net Cash |
99.33M |
| Net Cash / Share |
0.37 |
| Gross Margin |
31.81% |
| Operating Margin |
-61.22% |
| Profit Margin |
-7.00% |
| FCF Margin |
-110.29% |
| ROA |
0.06% |
| ROE |
1.68% |
| ROIC |
-1.90% |
Key stats in USD, based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (12)
| Buy |
8 |
| Overweight |
1 |
| Hold |
3 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$5.56*
(29.30% upside)
Low
3.95
Current: 4.30
High
7.20
Target: 5.56
*Average 12-month USD price target from 12 stock analysts.
Financial Performance
Financial numbers in millions CAD.
Financial Overview
| Year | 2019 | 2018 | 2017 |
|---|
| Revenue | 237 | 36.92 | 20.44 |
| Revenue Growth | 542.28% | 80.63% | - |
| Gross Profit | 75.42 | 40.89 | 17.30 |
| Operating Income | -145 | -12.43 | -1.39 |
| Net Income | -16.50 | 29.45 | 4.20 |
| Shares Outstanding | 243 | 161 | 104 |
| Earnings Per Share | -0.07 | 0.18 | 0.04 |
| EPS Growth | - | 350% | - |
| Operating Cash Flow | -55.61 | -5.65 | 5.33 |
| Capital Expenditures | -206 | -216 | -67.69 |
| Free Cash Flow | -262 | -222 | -62.36 |
| Cash & Equivalents | 622 | 107 | 167 |
| Total Debt | 489 | 31.09 | 33.43 |
| Net Cash / Debt | 133 | 75.65 | 134 |
| Assets | 2,442 | 1,314 | 316 |
| Liabilities | 708 | 140 | 42.10 |
| Book Value | 1,705 | 1,164 | 274 |
Numbers in millions CAD, except per-share numbers.
Company Details
| Full Name |
Aphria Inc. |
| Country |
Canada |
| Employees |
620 |
| CEO |
Irwin David Simon |
Stock Information
| Ticker Symbol |
APHA |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Drug Manufacturers—Specialty & Generic |
| Unique Identifier |
NASDAQ: APHA |
Description
Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis; and adult-use cannabis under the Solei, RIFF, Good Supply, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.